Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Expands Indication for Urticaria Drug to Treat Symptomatic Dermographism

(MedPage Today) -- The FDA expanded the indication of the Bruton's tyrosine kinase (BTK) inhibitor remibrutinib (Rhapsido) to treat symptomatic dermographism, the most common form of chronic inducible urticaria, Novartis announced Thursday. The...

FDA Expands Indication for Urticaria Drug to Treat Symptomatic Dermographism

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

How to define a measles death

Historically, the CDC relied on state health departments' determination of measles deaths. Now, it's working with the Council of State and Territorial Epidemiologists to create a clear definition.

Oguaa Omanhene endorses GMTF, says ‘There is hope for the future’

The Omanhene of the Oguaa Traditional Area, Osbarima Kwasi Atta II, has thrown his weight behind the Ghana Medical Trust Fund (GMTF), describing its interventions as a powerful source of hope for the future of healthcare delivery in Ghana. The Omanhene said the establishment of the Fund and the work it was undertaking to expand […]

Pain Prevalence Higher in Women, Increases Most Rapidly Before 55

Recent research has found that women experience pain more often than men and that pain prevalence increases more rapidly before the age of 55. ljubaphoto · E+/Getty A large global study found that pain prevalence increases most rapidly before age 55 and is consistently higher in women than men across 11 body sites.

More from Wednesday 7 October →